ABSTRACT
The vertebrate pituitary is arguably one of the most complex endocrine glands from the evolutionary, anatomical and functional perspectives. The pituitary plays a master role in endocrine physiology for the control of growth, metabolism, reproduction, water balance, and the stress response, among many other key processes. The synthesis and secretion of pituitary hormones are under the control of neurohormones produced by the hypothalamus. Under this conceptual framework, the communication between the hypophysiotropic brain and the pituitary gland is at the foundation of our understanding of endocrinology. The anatomy of the connections between the hypothalamus and the pituitary gland has been described in different vertebrate classes, revealing diverse modes of communication together with varying degrees of complexity. In this context, the evolution and variation in the neuronal, neurohemal, endocrine and paracrine modes will be reviewed in light of recent discoveries, and a re-evaluation of earlier observations. There appears to be three main hypothalamo-pituitary communication systems: 1. Diffusion, best exemplified by the agnathans; 2. Direct innervation of the adenohypophysis, which is most developed in teleost fish, and 3. The median eminence/portal blood vessel system, most conspicuously developed in tetrapods, showing also considerable variation between classes. Upon this basic classification, there exists various combinations possible, giving rise to taxon and species-specific, multimodal control over major physiological processes. Intrapituitary paracrine regulation and communication between folliculostellate cells and endocrine cells are additional processes of major importance. Thus, a more complex evolutionary picture of hypothalamo-hypophysial communication is emerging. There is currently little direct evidence to suggest which neuroendocrine genes may control the evolution of one communication system versus another. However, studies at the developmental and intergenerational timescales implicate several genes in the angiogenesis and axonal guidance pathways that may be important.
Subject(s)
Hypothalamo-Hypophyseal System/physiology , Vertebrates/physiology , Animals , Hypothalamo-Hypophyseal System/ultrastructure , Paracrine Communication , PhylogenyABSTRACT
The "ship" of the Arabian and North African deserts, the one-humped dromedary camel (Camelus dromedarius) has a remarkable capacity to survive in conditions of extreme heat without needing to drink water. One of the ways that this is achieved is through the actions of the antidiuretic hormone arginine vasopressin (AVP), which is made in a specialised part of the brain called the hypothalamo-neurohypophyseal system (HNS), but exerts its effects at the level of the kidney to provoke water conservation. Interestingly, our electron microscopy studies have shown that the ultrastructure of the dromedary HNS changes according to season, suggesting that in the arid conditions of summer the HNS is in an activated state, in preparation for the likely prospect of water deprivation. Based on our dromedary genome sequence, we have carried out an RNAseq analysis of the dromedary HNS in summer and winter. Amongst the 171 transcripts found to be significantly differentially regulated (>2 fold change, p value <0.05) there is a significant over-representation of neuropeptide encoding genes, including that encoding AVP, the expression of which appeared to increase in summer. Identification of neuropeptides in the HNS and analysis of neuropeptide profiles in extracts from individual camels using mass spectrometry indicates that overall AVP peptide levels decreased in the HNS during summer compared to winter, perhaps due to increased release during periods of dehydration in the dry season.
Subject(s)
Adaptation, Physiological , Camelus/physiology , Hypothalamo-Hypophyseal System/physiology , Seasons , Animals , Camelus/genetics , Gene Expression Profiling , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/ultrastructureABSTRACT
Hypothalamus plays a key role in homeostasis, and functions of the hypothalamus depend on the accurate trajectory of hypothalamic neuroendocrine axons. Thus, understanding the guidance of hypothalamic neuroendocrine axons is crucial for knowing how hypothalamus works. Previous studies suggest FGF10 deriving from the medial ventral midline of the hypothalamus plays an important role in axon guidance of the developing hypothalamus. Here we show that Shh and BMP7, which are from the anterior and posterior hypothalamic ventral midline respectively, together repel hypothalamic axons towards the medial ventral midline.
Subject(s)
Axons/physiology , Bone Morphogenetic Protein 7/physiology , Hedgehog Proteins/physiology , Hypothalamo-Hypophyseal System/physiology , Hypothalamus/physiology , Animals , Chick Embryo , Hypothalamo-Hypophyseal System/embryology , Hypothalamo-Hypophyseal System/ultrastructure , Hypothalamus/embryology , Hypothalamus/ultrastructureABSTRACT
OBJECTIVE: To observe the changes in ultrastructure and function of hypothalamic-pituitary-adrenal axis (HPAA), and to approach the relationship between them in early stage of sepsis in rats. METHODS: Thirty male Sprague-Dawley (SD) rats were randomly divided into normal control group, sham group, sepsis group. The sepsis model was reproduced by cecal ligation and puncture (CLP). The rats were sacrificed after collection of blood at 6 hours after CLP, and the levels of adrenocorticotropic hormone (ACTH) and corticosterone (CORT) in the plasma, and the corticotropin release hormone (CRH) in the tissue of hypothalamus were detected. The histopathological changes in HPAA were observed with transmission electron microscopy. RESULTS: The levels of ACTH and CORT in plasma, and the CRH in hypothalamus tissue of sepsis group were increased in the early stage of sepsis compared with the normal control group or sham group [ACTH (pmol/L): 5.78±0.36 vs. 1.94±0.31, 2.51±0.10; CORT (nmol/L): 88.48±4.47 vs. 22.02±1.62, 34.20±2.51; CRH (µg/L): 101.92±6.61 vs. 61.65±6.05, 66.65±4.03, P<0.05 or P<0.01]. The changes in ultrastructure of the hypothalamus, pituitary and adrenal were also found. In sepsis group, the ultrastructure of hypothalamus was as follows. Rough endoplasmic reticulum expansion and degranulation of rough endoplasmic reticulum, and swelling of Golgi complex were found. A large number of endocrine granules could be seen in ATCH cells in the pituitary with depletion of adrenal lipid droplets. CONCLUSION: In septic rats, the HPAA was excessively activated, and ACTH and CORT in plasma, and CRH in hypothalamus were significantly increased in early stage of sepsis. The changes in ultrastructure of HPAA were obvious, and the change in function was closely related to the ultrastructural changes.
Subject(s)
Hypothalamo-Hypophyseal System/metabolism , Pituitary-Adrenal System/metabolism , Sepsis/metabolism , Adrenocorticotropic Hormone/blood , Animals , Corticotropin-Releasing Hormone/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Hypothalamo-Hypophyseal System/ultrastructure , Male , Neurotransmitter Agents/metabolism , Pituitary-Adrenal System/physiopathology , Pituitary-Adrenal System/ultrastructure , Rats , Rats, Sprague-Dawley , Sepsis/pathology , Sepsis/physiopathologyABSTRACT
OBJECTIVE: To study the functional and ultramicrostructural effects of alpha lipoic acid on hypothalamus-pituitary-adrenal (HPA) axis in normal and diabetic rats. METHODS: Using radioimmunoassay we observed the effects of three doses (1, 20, and 100 mg/kg) of alpha lipoic acid injected intraperitoneally for 3 weeks on the plasma levels of CRH, ACTH and COR in normal and diabetic rats. The ultramicrostructural changes of the hypophysis and pituitary gland after alpha lipoic acid treatment were observed under transmission electron microscope. RESULTS: Compared with the control group, CRH level in lipoicin-treated normal and diabetic rats was significantly reduced (P<0.05). ACTH level of the 3 lipoicin doses groups of normal rats decreased, and a significant reduction occurred in medium-dose lipoicin group of diabetic rats (P<0.05). COR level showed the same changes as CRH level in normal rats, but decreased significantly in high- and medium-dose lipoicin groups of diabetic rats. Lipoicin treatment produced no apparent effect on the ultramicrostructures of the hypophysis and pituitary gland cells, which were the targets of diabetic lesions with low metabolism functions. Lipoicin treatment obviously enhanced the hypophysis and pituitary gland cell metabolism function to resist diabetic oxidative stress. CONCLUSION: Lipoicin can inhibit the HPA axis directly or indirectly in normal and diabetic rats.
Subject(s)
Hypothalamo-Hypophyseal System/drug effects , Pituitary-Adrenal System/drug effects , Thioctic Acid/pharmacology , Animals , Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Experimental/physiopathology , Hypothalamo-Hypophyseal System/physiology , Hypothalamo-Hypophyseal System/ultrastructure , Male , Pituitary-Adrenal System/diagnostic imaging , Pituitary-Adrenal System/physiology , Random Allocation , Rats , Rats, Sprague-Dawley , UltrasonographyABSTRACT
The hypothalamo-neurohypophysial system (HNS) consisting of arginine vasopressin (AVP) and oxytocin (OXT) magnocellular neurons shows the structural plasticity including the rearrangement of synapses, dendrites, and neurovascular contacts during chronic physiological stimulation. In this study, we examined the remodeling of chondroitin sulfate proteoglycans (CSPGs), main extracellular matrix (ECM), in the HNS after salt loading known as a chronic stimulation to cause the structural plasticity. In the supraoptic nucleus (SON), confocal microscopic observation revealed that the immunoreactivity of 6B4 proteoglycans (PG) was observed mainly at AVP-positive magnocellular neurons but that of neurocan was seen chiefly at OXT-positive magnocellular neurons. The immunoreactivity of phosphacan and aggrecan was seen at both AVP- and OXT-positive magnocellular neurons. Electron microscopic observation further showed that the immunoreactivity of phosphacan and neurocan was observed at astrocytic processes to surround somata, dendrites, and terminals, but not synaptic junctions. In the neurohypophysis (NH), the immunoreactivity of phosphacan, 6B4 PGs, and neurocan was observed at AVP-positive magnocellular terminals, but the reactivity of Wisteria floribunda agglutinin lectin was seen at OXT-positive ones. The immunoreactivity of versican was found at microvessel and that of aggrecan was not detected in the NH. Quantitative morphometrical analysis showed that the chronic physiological stimulation by 7-day salt loading decreased the level of 6B4 PGs in the SON and the level of phosphacan, 6B4 PGs, and neurocan in the NH. These results suggest that the extracellular microenvironment of CSPGs is different between AVP and OXT magnocellular neurons and activity-dependent remodeling of CSPGs could be involved in the structural plasticity of the HNS.
Subject(s)
Chondroitin Sulfate Proteoglycans/metabolism , Extracellular Matrix/metabolism , Hypothalamo-Hypophyseal System/metabolism , Hypothalamus/metabolism , Neuronal Plasticity/physiology , Pituitary Gland, Posterior/metabolism , Aggrecans/metabolism , Animals , Arginine Vasopressin/metabolism , Hypothalamo-Hypophyseal System/ultrastructure , Hypothalamus/ultrastructure , Immunohistochemistry , Male , Microscopy, Confocal , Microscopy, Electron, Transmission , Neurocan , Neuronal Plasticity/drug effects , Oxytocin/metabolism , Pituitary Gland, Posterior/ultrastructure , Plant Lectins/metabolism , Presynaptic Terminals/metabolism , Rats , Rats, Wistar , Receptor-Like Protein Tyrosine Phosphatases, Class 5/metabolism , Receptors, N-Acetylglucosamine/metabolism , Sodium Chloride/pharmacology , Supraoptic Nucleus/metabolism , Supraoptic Nucleus/ultrastructure , Versicans/metabolism , Water-Electrolyte Balance/physiologyABSTRACT
Systemic injection of lipopolysaccharide (LPS) is a widely used model of immune/inflammatory challenge, which can invoke a host of CNS responses, including activation of the hypothalamic-pituitary-adrenal (HPA) axis. Inducible vascular prostaglandin E(2) (PGE(2)) synthesis by endothelial (ECs) and/or perivascular cells (PVCs) (a macrophage-derived vascular cell type) is implicated in the engagement of HPA and other CNS responses, by virtue of their capacity to express cyclooxygenase-2 (COX-2) and microsomal PGE(2) synthase-1. Evidence from genetic and pharmacologic studies also supports a role for the constitutively expressed COX-1 in inflammation-induced activation of the HPA axis, although histochemical evidence to support relevant localization(s) and regulation of COX-1 expression is lacking. The present experiments fill this void in showing that COX-1 immunoreactivity (IR) and mRNA are detectable in identified PVCs and parenchymal microglia under basal conditions and is robustly expressed in these and ECs 1-3 h after intravenous injection of LPS (2 microg/kg). Confocal and electron microscopic analyses indicate distinct cellular/subcellular localizations of COX-1-IR in the three cell types. Interestingly, COX-1 expression is enhanced in ECs of brain PVC-depleted rats, supporting an anti-inflammatory role of the latter cell type. Functional involvement of COX-1 is indicated by the observation that central, but not systemic, pretreatment with the selective COX-1 inhibitor SC-560 attenuated the early phase of LPS-induced increases in adrenocorticotropin and corticosterone secretion. These findings support an involvement of COX-1 in bidirectional interplay between ECs and PVCs in initiating vascular PGE(2) and downstream HPA response to proinflammatory challenges.
Subject(s)
Cyclooxygenase 1/metabolism , Hypothalamo-Hypophyseal System/metabolism , Inflammation/pathology , Pituitary-Adrenal System/metabolism , Adrenocorticotropic Hormone/metabolism , Animals , Corticosterone/metabolism , Cyclooxygenase 1/deficiency , Cyclooxygenase 1/genetics , Cyclooxygenase Inhibitors/pharmacology , Dinoprostone/metabolism , Disease Models, Animal , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/physiopathology , Hypothalamo-Hypophyseal System/ultrastructure , Immunoenzyme Techniques/methods , Inflammation/chemically induced , Injections, Intraventricular/methods , Interleukin-1beta/administration & dosage , Lipopolysaccharides , Liposomes/metabolism , Male , Mice , Mice, Knockout , Microscopy, Electron, Transmission/methods , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/physiopathology , Pituitary-Adrenal System/ultrastructure , Pyrazoles/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , von Willebrand Factor/metabolismABSTRACT
Previous studies revealed that oxytocin release is increased by various forms of stress. Hypertonic saline injection, immobilization, and several other stressors elevated the blood level of oxytocin in rats. However, the mechanism of the stress-induced oxytocin release in human is not elucidated yet. Although numerous studies indicate that catecholamines play a pivotal role in modulating the release of oxytocin, there is a lack of data regarding the morphological substrate of this phenomenon. In order to reveal putative juxtapositions between tyrosine hydroxylase-immunoreactive (TH-IR) catecholaminergic and the oxytocinergic systems in the human hypothalamus, we utilized double-label immunohistochemistry in the present study. Numerous TH-IR axon varicosities abutted on oxytocin-IR neurons in the supraoptic and paraventricular nuclei, forming synapse-like associations. Close examination of these juxtapositions with high magnification failed to reveal any gaps between the contacting elements. In summary, the intimate associations between the TH-IR and oxytocin-IR elements may be functional synapses and may represent the morphological substrate of stress-influenced oxytocin release. The finding that several oxytocin-IR perikarya did not receive apparent TH innervation suggests that additional mechanisms may play significant roles in the oxytocin modulation by stressors.
Subject(s)
Catecholamines/metabolism , Hypothalamo-Hypophyseal System/metabolism , Hypothalamus/metabolism , Neural Pathways/metabolism , Neurosecretion/physiology , Oxytocin/metabolism , Aged , Aged, 80 and over , Biomarkers/analysis , Biomarkers/metabolism , Brain Mapping , Female , Humans , Hypothalamo-Hypophyseal System/ultrastructure , Hypothalamus/ultrastructure , Immunohistochemistry , Male , Middle Aged , Neural Pathways/ultrastructure , Paraventricular Hypothalamic Nucleus/metabolism , Paraventricular Hypothalamic Nucleus/ultrastructure , Presynaptic Terminals/metabolism , Presynaptic Terminals/ultrastructure , Stress, Psychological/metabolism , Stress, Psychological/physiopathology , Supraoptic Nucleus/metabolism , Supraoptic Nucleus/ultrastructure , Synaptic Transmission/physiology , Tyrosine 3-Monooxygenase/analysis , Tyrosine 3-Monooxygenase/metabolismABSTRACT
Morphofunctional equivalents of the process of long-term intracellular prokaryotes--eukaryotes interaction were studied by light and electron microscopy. The mechanisms for adaptation, elaborated in the course of evolution of bacteria-host interaction, were analysed on the ultrastructural level. A concept on the role of hypothalamic nonapeptides, as factors of regulation of intracellular persistence and symbiosis of prokaryotes, is discussed.
Subject(s)
Escherichia coli/physiology , Eukaryotic Cells/microbiology , Eukaryotic Cells/ultrastructure , Providencia/physiology , Staphylococcus aureus/physiology , Animals , Bronchi/microbiology , Bronchi/pathology , Endocytosis , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/microbiology , Hypothalamo-Hypophyseal System/ultrastructure , Hypothalamus/metabolism , Hypothalamus/ultrastructure , Male , Mammals , Mouth Mucosa/microbiology , Mouth Mucosa/pathology , Palate, Soft/microbiology , Peptides/metabolism , Peptides/physiology , Rats , Respiratory Mucosa/microbiology , Respiratory Mucosa/pathology , Secretory Vesicles/ultrastructure , SymbiosisABSTRACT
The intrinsic expression of sex hormone binding globulin (SHBG) in magnocellular hypothalamic neurons, in part co-localized with either vasopressin or oxytocin, was recently described. This study is focused on the ultrastructural localization of SHBG in the hypothalamo-neurohypophyseal pathway in rats. Immunostaining for SHBG in the hypothalamic perikarya was increased by colchicine treatment, indicating that the steroid-binding globulin is subject to rapid axoplasmic transport along with the classical posterior lobe peptides. With immunoelectron-microscopic double labeling, we found co-localization of oxytocin and sex hormone binding globulin in a portion of the large dense-core vesicles in paraventricular and supraoptic perikarya and in axonal varicosities in the median eminence and in the posterior lobe. Our observations show that SHBG is processed, transported and stored along with oxytocin suggesting that SHBG is released from nerve terminals in the posterior lobe, the median eminence and possibly the brain similarly to and in conjunction with oxytocin.
Subject(s)
Hypothalamo-Hypophyseal System/metabolism , Oxytocin/metabolism , Sex Hormone-Binding Globulin/metabolism , Symporters/metabolism , Transport Vesicles/metabolism , Animals , Female , Hypothalamo-Hypophyseal System/ultrastructure , Immunohistochemistry , Male , Microscopy, Immunoelectron , Oxytocin/immunology , Rats , Rats, Wistar , Sex Hormone-Binding Globulin/immunologyABSTRACT
Brain-derived neurotrophic factor (BDNF) is immunocytochemically demonstrated in the magnocellular nucleus and neural lobe of the pituitary gland of the amphibian Xenopus laevis. Immunoelectron microscopy shows BDNF in secretory granules of type A neurohemal axon terminals in the neural lobe of pituitary gland. It is proposed that BDNF released from the neural lobe acts as a neurohormone stimulating the secretory activity of the melanotrope cells in the intermediate pituitary lobe.
Subject(s)
Brain-Derived Neurotrophic Factor/physiology , Hypothalamo-Hypophyseal System/chemistry , Xenopus Proteins/physiology , Animals , Brain-Derived Neurotrophic Factor/metabolism , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/ultrastructure , Pituitary Gland/chemistry , Pituitary Gland/metabolism , Pituitary Gland/ultrastructure , Xenopus Proteins/metabolism , Xenopus laevisABSTRACT
To determine whether GABA-ergic axons are anatomically situated to directly influence TRH neurons in the PVN, double-labeling light- and electronmicroscopic immunocytochemistry was performed using antisera against glutamic acid decarboxylase (GAD) and prothyrotropin-releasing hormone (proTRH). In the anterior, periventricular and medial parvocellular subdivisions of the PVN, GAD-immunoreactive (IR) axon varicosities were closely apposed to all proTRH containing cell bodies and proximal dendrites. Ultrastucturally, GAD-IR nerve terminals established symmetric type synapses with both perikarya and dendrites of proTRH-IR neurons, indicating the inhibitory nature of the contacts. Since a subpopulation of neuropeptide Y (NPY) neurons in the hypothalamic arcuate nucleus co-synthesize GABA, and NPY-containing neurons of arcuate nucleus origin densely innervate TRH neurons in the PVN, we performed triple labeling immunocytochemistry to elucidate the origin of the GAD-IR innervation of hypophysiotropic TRH neurons. While axons co-containing GAD and NPY were observed throughout the PVN, only approximately 10% of GAD-IR terminals in contact with TRH neurons were found to contain NPY-immunoreactivity. We conclude that GABA-ergic neurons are in position to act directly on hypophysiotropic TRH neurons and while this innervation arises partly from neurons in the arcuate nucleus that co-synthesize NPY, the majority of the GABA-ergic input arises from other neuronal groups.
Subject(s)
Afferent Pathways/metabolism , Dendrites/metabolism , Paraventricular Hypothalamic Nucleus/metabolism , Presynaptic Terminals/metabolism , Thyrotropin-Releasing Hormone/biosynthesis , gamma-Aminobutyric Acid/metabolism , Afferent Pathways/ultrastructure , Animals , Arcuate Nucleus of Hypothalamus/metabolism , Arcuate Nucleus of Hypothalamus/ultrastructure , Dendrites/ultrastructure , Energy Metabolism/physiology , Food Deprivation/physiology , Glutamate Decarboxylase/metabolism , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/ultrastructure , Immunohistochemistry , Male , Microscopy, Electron , Neural Inhibition/physiology , Neuropeptide Y/metabolism , Paraventricular Hypothalamic Nucleus/ultrastructure , Presynaptic Terminals/ultrastructure , Rats , Rats, Wistar , Synaptic Transmission/physiology , Thyroid Hormones/metabolism , Thyrotropin-Releasing Hormone/metabolismABSTRACT
Agmatine, decarboxylated from arginine by arginine decarboxylase, is particularly prominent in the hypothalamus. The present study utilized the rat hypothalamo-neurohypophysial system to determine expression and "pre-synaptic" modulation of agmatine in the central nervous system (CNS). Under confocal-laser scanning, agmatine-like immunoreactivity (Agm-LI) was found enriched in arginine-vasopressin (AVP)-containing magnocellular neurons of the supraoptic nuclei (SON) and paraventricular nuclei (PVN). In addition, using electron microscopy, Agm-LI was found closely associated with large neurosecretory-like vesicles in neurohypophysial nerve terminals of posterior pituitary gland. Radioimmunoassay revealed that 10 and 30 microM agmatine concentration-dependently inhibited the depolarization-evoked AVP release from isolated neurohypophysial terminals. Using perforated patch-clamp, effects of agmatine on whole-terminal voltage-gated ion currents in the isolated neurohypophysial nerve terminals were examined. While it did not significantly affect either tetrodotoxin (TTX)-sensitive Na(+) or sustained Ca(2+)-activated K(+) channel currents, agmatine (1-40 microM) inhibited Ca(2+) channel currents in approximately 53% of the total nerve terminals investigated. The onset of inhibitory effect was immediate, and the inhibition was reversible and concentration-dependent with an IC(50)=4.6 microM. In the remaining (approximately 47%) neurohypophysial nerve terminals, only a higher (120 microM) concentration of agmatine could moderately inhibit Ca(2+) channel currents. The results suggest that: (1) endogenous agmatine is co-expressed in AVP-containing, hypothalamic magnocellular neurons of the SON/PVN and in neurohypophysial nerve terminals of posterior pituitary gland; (2) agmatine may serve as a physiological neuromodulator by regulating the voltage-gated Ca(2+) channel and, as a result, the release of AVP from neurohypophysial nerve terminals.
Subject(s)
Agmatine/metabolism , Calcium Channels/physiology , Hypothalamo-Hypophyseal System/physiology , Neurons/physiology , Vasopressins/metabolism , Agmatine/analysis , Agmatine/pharmacology , Animals , Calcium Channels/analysis , Hypothalamo-Hypophyseal System/chemistry , Hypothalamo-Hypophyseal System/ultrastructure , Male , Neurons/chemistry , Neurons/ultrastructure , Paraventricular Hypothalamic Nucleus/chemistry , Paraventricular Hypothalamic Nucleus/physiology , Paraventricular Hypothalamic Nucleus/ultrastructure , Rats , Rats, Sprague-Dawley , Supraoptic Nucleus/chemistry , Supraoptic Nucleus/physiology , Supraoptic Nucleus/ultrastructure , Vasopressins/analysisABSTRACT
The distribution of the purine receptor P2X(6) subtype was studied in the rat hypothalamo-neurohypophysial system at the electron microscope level. Receptors were visualised with ExtrAvidin peroxidase conjugate and immunogold-silver pre-embedding immunocytochemistry using a polyclonal antibody against an intracellular domain of the receptor. Application of ExtrAvidin labelling revealed P2X(6) receptors in subpopulations of: (i) neurosecretory cell bodies, neurosecretory and non-neurosecretory axons and dendrites of neurones in the paraventricular and supraoptic nuclei; and (ii) pituicytes and neurosecretory axons of the neurohypophysis. Some of the neurosecretory granules observed in the supraoptic and paraventricular nuclei neurone cell bodies, dendrites and axons as well as those in neurohypophysial axons were also positive for the P2X(6) receptors. In the paraventricular nucleus, some axons and dendrites of non-neurosecretory neurones positive for P2X(6) receptors formed synapses between themselves. Using the immunogold-silver method, the electron-dense particles labelling P2X(6) receptors were found in neurosecretory cell bodies of the supraoptic and paraventricular nuclei, in relation to the cytoplasm, endoplasmic reticulum, Golgi complex and neurosecretory granules. The particles indicative of P2X(6) receptors were also located in neurosecretory and non-neurosecretory axons including axonal buttons making synapses with P2X(6)-negative dendrites. In the neurohypophysis, the electron-dense particles were localised in a subpopulation of pituicytes and neurosecretory axons. In neurohypophysial axons, particles were at times seen over the membrane of some neurosecretory granules (immunogold label) or microvesicles (immunoperoxidase label). We speculate that the P2X(6) receptors at the neurohypophysial level may be implicated not only in hormone release from the axon terminals, but also in membrane recycling of the granular vesicles and microvesicles.
Subject(s)
Dendrites/metabolism , Hypothalamo-Hypophyseal System/metabolism , Pituitary Gland, Posterior/metabolism , Presynaptic Terminals/metabolism , Receptors, Purinergic P2/metabolism , Animals , Avidin/immunology , Dendrites/ultrastructure , Gold Colloid , Hypothalamo-Hypophyseal System/ultrastructure , Immunohistochemistry/methods , Male , Microscopy, Electron , Paraventricular Hypothalamic Nucleus/metabolism , Paraventricular Hypothalamic Nucleus/ultrastructure , Pituitary Gland, Posterior/ultrastructure , Presynaptic Terminals/ultrastructure , Rats , Rats, Sprague-Dawley , Secretory Vesicles/metabolism , Secretory Vesicles/ultrastructure , Supraoptic Nucleus/metabolism , Supraoptic Nucleus/ultrastructureABSTRACT
Interleukin-1beta has been demonstrated in neurons of the rat hypothalamus, including cells of the magnocellular neurosecretory system and tuberoinfundibular system (Lechan et al., [1990] Brain Res. 514:135-140). Despite its potential importance to regulation of neuroendocrine function, however, neither the specific cell types that express interleukin-1beta or the conditions that may result in its release have yet been described. Therefore, we utilized a combination of immunocytochemical and immunoelectron microscopic localization, in conjunction with Western blot analysis, on normonatremic, hypernatremic, and lactating rats to assess the site of synthesis and potential secretion characteristics of interleukin-1beta in the rat magnocellular neurosecretory system. Interleukin-1beta immunoreactivity was localized within both oxytocin and vasopressin neurons in the paraventricular, supraoptic, accessory and periventricular hypothalamic nuclei. Additionally, interleukin-1beta immunoreactive fibers were localized in the zona interna and zona externa of the median eminence and in the neurohypophysis. Immunoelectron microscopic analysis revealed that interleukin-1beta immunoreactivity is associated with small spherical structures, distinct from neurosecretory granules, in neurosecretory axons within the neurohypophysis. Furthermore, stimulation of heightened neurosecretory activity via chronic osmotic challenge and lactation resulted in a marked diminution in levels of interleukin-1beta immunoreactivity in the neurohypophysis with a subsequent return to normal levels after cessation of the stimuli. Western blot analysis confirmed the existence of interleukin-1beta protein in the neurohypophysis and provided further evidence for reduction in levels of IL-1beta immunoreactivity after stimulation of secretory activity. These results suggest an endogenous neuronal source of interleukin-1beta exists within the rat magnocellular neurosecretory system under normal physiological conditions. The potential for activity-dependent release of IL-1beta and implications for the involvement of interleukin-1beta in regulation of neurosecretory activity are discussed.
Subject(s)
Hypothalamo-Hypophyseal System/metabolism , Interleukin-1/metabolism , Neurons/metabolism , Neurosecretory Systems/metabolism , Animals , Arginine Vasopressin/metabolism , Axons/metabolism , Axons/ultrastructure , Blotting, Western , Hypothalamo-Hypophyseal System/cytology , Hypothalamo-Hypophyseal System/ultrastructure , Hypothalamus/cytology , Hypothalamus/metabolism , Hypothalamus/ultrastructure , Male , Microglia/cytology , Microglia/metabolism , Microscopy, Immunoelectron , Neurons/cytology , Neurons/ultrastructure , Neurosecretory Systems/cytology , Neurosecretory Systems/ultrastructure , Oxytocin/metabolism , Pituitary Gland/cytology , Pituitary Gland/metabolism , Pituitary Gland/ultrastructure , Rats , Rats, Sprague-DawleyABSTRACT
The relationship between the cloned kappa opioid receptor, dynorphin, and the neurohypophysial hormones vasopressin and oxytocin was analysed in the guinea-pig hypothalamic magnocellular neurosecretory neurons. This analysis was performed in order to understand better which population of neuroendocrine neurons in the guinea-pig is modulated by kappa opioid receptors and its endogenous ligand dynorphin. Extensive co-localization was observed between kappa opioid receptor immunoreactivity and preprodynorphin immunoreactivity in neuronal cell bodies in the paraventricular and supraoptic nuclei. Cells positive for either the kappa opioid receptor or both the kappa opioid receptor and preprodynorphin were restricted to the vasopressin expressing neuronal population and not found in the oxytocin expressing neuronal population. The kappa opioid receptor and dynorphin were examined in the posterior pituitary and both were found to be extensively distributed. Staining for the kappa opioid receptor and dynorphin B co-localized in posterior pituitary. In addition, immunogold electron microscopy confirmed that kappa opioid receptor and dynorphin B immunoreactivity were found in the same nerve terminals. Ultrastructural analysis also revealed that kappa opioid receptor immunoreactivity was associated with both nerve terminals and pituicytes. Within nerve terminals, kappa opioid receptor immunoreactivity was often associated with large secretory vesicles and rarely associated with the plasma membrane. Our data suggest that the cloned kappa opioid receptor may directly modulate the release of vasopressin but not oxytocin in guinea-pig hypothalamic magnocellular neurosecretory neurons and posterior pituitary. Furthermore, we propose that this receptor is an autoreceptor in this system because our results demonstrate a high degree of co-localization between kappa opioid receptor and dynorphin peptide immunoreactivity in magnocellular nerve terminals.
Subject(s)
Dynorphins/metabolism , Hypothalamo-Hypophyseal System/metabolism , Neurons/metabolism , Paraventricular Hypothalamic Nucleus/metabolism , Receptors, Opioid, kappa/metabolism , Supraoptic Nucleus/metabolism , Vasopressins/metabolism , Animals , Female , Guinea Pigs , Hypothalamo-Hypophyseal System/ultrastructure , Immunohistochemistry , Male , Microscopy, Electron , Neurons/ultrastructure , Paraventricular Hypothalamic Nucleus/ultrastructure , Pituitary Gland, Posterior/metabolism , Pituitary Gland, Posterior/ultrastructure , Supraoptic Nucleus/ultrastructureABSTRACT
Cocaine and amphetamine regulated transcript (CART) has been identified as one of the most abundant mRNAs in the rat hypothalamus. The objective of the present study was to elucidate the distribution of CART peptide immunoreactive (CARTir) neurons in the monkey hypothalamus and characterize their ultrastructural features and synaptic connections in the paraventricular nucleus (PVN). CARTir neurons were particularly abundant in the PVN, supraoptic nucleus (SON), infundibular nucleus, and premammillary nucleus, whereas the anterior, lateral, and posterior hypothalamic areas as well as the posterior nucleus displayed moderate immunoreactivity. Dense bundles of CARTir fibers exited the PVN and SON and followed a trajectory to the infundibulum similar to that previously shown for vasopressin and oxytocin fibers. The posterior pituitary was densely packed with large CARTir varicosities which, in some cases, were apposed to labeled pituicytes. The external/palisade zone of the median eminence contained rich plexuses of small CARTir varicose fibers, and the internal/fibrous zone was enriched in large axon-like processes. Electron microscope analysis of the PVN revealed (1) that CART peptide immunoreactivity is found in neurosecretory and non-neurosecretory neurons contacted predominantly by unlabelled terminals forming asymmetric synapses, (2) that CARTir terminals resemble glutamatergic and/or noradrenergic boutons and form asymmetric synapses with non-neurosecretory dendrites, and (3) that neuropeptide Y (NPY)-containing terminals are apposed to CARTir neurons in the medial part of the nucleus. In conclusion, our findings demonstrate that CART peptide is abundant in neuronal perikarya and axon terminals throughout the monkey hypothalamus and along the hypothalamopituitary axis. This strengthens the idea that CART peptides may act as putative neurotansmitters/neuromodulators that mediate various neuroendocrine and autonomic functions in primates.
Subject(s)
Macaca mulatta/anatomy & histology , Nerve Tissue Proteins/analysis , Paraventricular Hypothalamic Nucleus/chemistry , Paraventricular Hypothalamic Nucleus/ultrastructure , Pituitary Gland/chemistry , Pituitary Gland/ultrastructure , Presynaptic Terminals/chemistry , Presynaptic Terminals/ultrastructure , Animals , Hypothalamo-Hypophyseal System/chemistry , Hypothalamo-Hypophyseal System/ultrastructure , Immunohistochemistry , Neurons/chemistry , Neurons/ultrastructure , Neuropeptide Y/analysis , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/ultrastructureABSTRACT
The hypothalamo-neurohypophysial tract of young, adult and aged male hamsters was studied at lateral and ventral regions of hypothalamus by means of electron microscopy. Neurosecretory swelling axons (Herring bodies) were usually found as classically described containing abundant neurosecretory granules, mitochondria, few microtubules and profiles of smooth endoplasmic reticulum in all groups of age. However, in aged hamsters, starting at 18-month-old subjects, we observed that the size of some neurosecretory axons was highly increased. Autophagic and degenerative features were seen in the larger ones. These data could suggest abnormal axonal storage or axonal transport blocked during aging. The implications in the role of hypothalamus-neurohypophysial system during aging are discussed.
Subject(s)
Aging/pathology , Axons/ultrastructure , Animals , Cricetinae , Hypothalamo-Hypophyseal System/ultrastructure , Hypothalamus/ultrastructure , Male , MesocricetusABSTRACT
The distribution of the P2X(2) subtype of the purine receptor associated with the extracellular signalling activities of ATP was studied in the rat hypothalamo-neurohypophysial system at the electron microscope level. Receptors were labelled with ExtrAvidin-horseradish peroxidase preembedding immunocytochemistry using a polyclonal antibody against a fragment of an intracellular domain of the receptor. Immunoreactivity to P2X(2) receptors was localised in: (i) paraventricular and supraoptic nuclei-in subpopulations of endocrine neurones, neurosecretory and non-neurosecretory axons and dendrites; and (ii) the neurohypophysis-in pituicytes and subpopulation of neurosecretory axons. In both the hypothalamic nuclei examined, labelled asymmetric axo-dendritic synapses were commonly observed. These synapses involved either P2X(2)-labelled axon terminals (synaptic buttons) and unlabelled dendrites or labelled dendrites and unlabelled axon terminals. Axo-somatic synapses established by P2X(2)-positive axons on P2X(2)-positive endocrine cell bodies as well as on P2X(2)-negative somata were also observed. The functional significance of these findings is discussed.
Subject(s)
Adenosine Triphosphate/metabolism , Hypothalamo-Hypophyseal System/physiology , Neurons/physiology , Receptors, Purinergic P2/metabolism , Animals , Cytoplasmic Granules/physiology , Cytoplasmic Granules/ultrastructure , Dendrites/physiology , Dendrites/ultrastructure , Hypothalamo-Hypophyseal System/ultrastructure , Male , Microscopy, Immunoelectron , Neurons/ultrastructure , Paraventricular Hypothalamic Nucleus/physiology , Paraventricular Hypothalamic Nucleus/ultrastructure , Pituitary Gland, Posterior/physiology , Pituitary Gland, Posterior/ultrastructure , Rats , Rats, Sprague-Dawley , Receptors, Purinergic P2/analysis , Receptors, Purinergic P2X2 , Supraoptic Nucleus/physiology , Supraoptic Nucleus/ultrastructure , Synaptic Vesicles/physiology , Synaptic Vesicles/ultrastructureABSTRACT
A mouse model for binge drinking has been developed in this laboratory, and several aspects of this model have been characterized. Many of the immunosuppressive effects of ethanol (EtOH) in this model seem to be mediated by activation of the hypothalamic-pituitary-adrenal (HPA) axis and consequent increases in the concentration of glucocorticoids, catecholamines, and perhaps other immunosuppressive mediators. The purpose of the work described here is to examine three important issues regarding the EtOH-induced neuroendocrine response in this model: 1) Are Ro15-4513-sensitive gamma aminobutyric acid type A (GABA-A) receptors involved in activation of the HPA axis by EtOH? 2) Does daily administration of EtOH produce tolerance with regard to activation of the HPA axis or with regard to suppression of natural killer cell activity? 3) Is the HPA axis activated by similar blood EtOH concentrations in humans and in the mouse model? Ro15-4513, a partial inverse agonist of GABA-A receptors, did not affect EtOH-induced increases in blood corticosterone levels. This suggests that Ro15-4513-sensitive GABA-A receptors are not involved in EtOH-induced activation of the HPA axis and that inhibition of corticosterone production is not the mechanism by which Ro-15-4513 blocks EtOH-induced immunosuppression. To evaluate tolerance, mice were given a daily dose of EtOH (6.5 g/kg by gavage) or vehicle (water) for 10 days. Control groups received vehicle or EtOH only on the last day of the experiment. At the optimum time after EtOH administration serum corticosterone and splenic NK cell activity were measured. The results indicate no significant alterations in the response to EtOH of mice exposed to EtOH for 10 days compared to those exposed only once. To compare the HPA axis response of mice and humans, lower EtOH dosages than generally used in our model were administered to mice, and the corticosterone response was compared to published data for humans who had similar ranges of blood EtOH levels. The results suggest that humans and mice exhibit activation of the HPA axis only when blood EtOH levels exceed approximately 0.14%. Together these results further characterize a mouse model for binge drinking that seems to provide a reasonable representation of many aspects of binge drinking in humans.